Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNCE and other ETFs, options, and stocks.
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treats cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Its product pipeline includes JTX-2011 (ICOS), JTX-4014 (PD-1), the Lead Macrophage Program, Macrophage Targeting, T Reg, B Cells, and Stromal Targeting.
52 Week high
52 Week low
— per share
Expected Aug 4, Pre-Market